novolin n
Pharmaranks rates Novolin N 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Novolin N (Insulin Susp Isophane Recombinant Human) is a medication supplied as an injection, suspension.
Insulin Susp Isophane Recombinant Human · by Novo Nordisk Inc
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Insulin Susp Isophane Recombinant Human
- Form
- Injectable
- Strength
- Insulin Susp Isophane Recombinant Human 100 UNITS/ML
- Type
- Over-the-counter (OTC)
- Brand or generic
- Brand-name
- Manufacturer
- Novo Nordisk Inc
- FDA application
- BLA019959
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How is Novolin N rated?
- pharmaranks gives Novolin N a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Novolin N?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Novolin N. To pay less, look for a store-brand version with the same active ingredient (Insulin Susp Isophane Recombinant Human), which is typically cheaper, and compare unit prices. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Novolin N?
- Novolin N is marketed by Novo Nordisk Inc. You can see Novo Nordisk Inc's full profile, rating, and other products on pharmaranks.
- Is Novolin N a brand-name or generic drug?
- Novolin N is a brand-name product with the active ingredient Insulin Susp Isophane Recombinant Human.
- Is Novolin N available over the counter?
- Yes. Novolin N is an over-the-counter (OTC) product — you can buy it without a prescription. Follow the label directions and ask a pharmacist if you're unsure whether it's right for you.
- What forms does Novolin N come in?
- Novolin N is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Novolin N FDA-registered?
- Novolin N is on record with the U.S. FDA under application number BLA019959. You can verify this on its official FDA label.
- Has Novolin N been recalled by the FDA?
- Novolin N has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Novolin N safe?
- There's no single safe-or-not verdict. pharmaranks gives Novolin N a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 8 reports naming INSULIN SUSP ISOPHANE RECOMBINANT HUMAN — the active ingredient in Novolin N, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- hypoglycaemic coma2 reports
- arthralgia1 reports
- confusional state1 reports
- diabetic coma1 reports
- fall1 reports
- hospitalisation1 reports
- impaired healing1 reports
- muscular weakness1 reports
Read these as a signal, not a rate. A report does not mean INSULIN SUSP ISOPHANE RECOMBINANT HUMAN caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Novolin N head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
novolin n
70/100